Theravance Biopharma, Inc.

TBPH

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001583107

SEC filings (opens in a new tab)

In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Theravance Biopharma, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of TBPH: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	128	2	132	+6
Shares	44.9M	496.0K	44.9M	+503.4K (+1.1%)
Value	$422.4M	$4.67M	$400.9M	−$16.8M (−4.0%)

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Theravance Biopharma, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to TBPH in Q1 2025
Institution	Shares	Value	% of portfolio
Nuveen, LLC	374,952	$3.35M	0.00%
Arrowstreet Capital, Limited Partnership	221,469	$1.98M	0.00%
Qube Research & Technologies Ltd	113,939	$1.02M	0.00%
Cubist Systematic Strategies, LLC	46,972	$419.5K	0.01%
Virtus Investment Advisers, Inc.	36,379	$324.9K	0.09%
ExodusPoint Capital Management, LP	28,437	$254.0K	0.00%
Two Sigma Advisers, LP	24,700	$220.6K	0.00%
Jefferies Financial Group Inc.	21,432	$191.4K	0.00%
Brookwood Investment Group LLC	21,060	$188.1K	0.03%
HRT Financial LP	17,490	$156.0K	0.00%
Verition Fund Management LLC	14,647	$130.8K	0.00%
AQR Capital Management LLC	11,270	$100.6K	0.00%
Prudential Financial Inc	10,140	$90.5K	0.00%
Point72 Asia (Singapore) Pte. Ltd.	6,045	$54.0K	0.01%
Point72 (DIFC) Ltd	2,839	$25.4K	0.00%
Coldstream Capital Management Inc	2,346	$21.0K	0.00%
Versant Capital Management, Inc	857	$7.65K	0.00%
Point72 Hong Kong Ltd	400	$3.57K	0.00%
Caitong International Asset Management Co., Ltd	258	$2.30K	0.00%
Larson Financial Group LLC	54	$482	0.00%
CoreCap Advisors, LLC	27	$241	0.00%
True Wealth Design, LLC	3	$27	0.00%
Simplex Trading, LLC	106	$0	0.00%

Sold out (17)

Institutions that held Theravance Biopharma, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of TBPH in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
UBS Asset Management Americas Inc	150,039	$1.41M
Swiss National Bank	71,742	$675.1K
Ensign Peak Advisors, Inc	60,907	$573.1K
State of Wisconsin Investment Board	58,001	$545.8K
Virtus ETF Advisers LLC	35,426	$333.4K
Janus Henderson Group PLC	24,666	$232.4K
Engineers Gate Manager LP	19,832	$186.6K
ClearAlpha Technologies LP	11,586	$109.0K
Teacher Retirement System of Texas	10,937	$103.0K
Arizona State Retirement System	10,649	$100.2K
Man Group plc	10,328	$97.2K
Gerber, LLC	10,000	$94.1K
KLP Kapitalforvaltning AS	7,300	$68.7K
Creative Planning	603	$5.67K
Venturi Wealth Management, LLC	526	$4.95K
Parallel Advisors, LLC	240	$2.26K
Lindbrook Capital, LLC	14	$132

Not filed for Q1 2025 yet (2)

Institutions that held Theravance Biopharma, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TBPH in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	495,727	$4.66M
Global Retirement Partners, LLC	300	$2.82K